Mary-Claire King and Andrew Futreal interviewed by Jan Witkowski [post-production version]

Preserved in 2020-2022 through a CLIR Recordings at Risk grant. This interview video is available for use under a CC0 1.0 Universal license.

Dr. Mary-Claire King is a geneticist that was the first to show that breast cancer can be inherited due to mutations in the BRCA1 gene. She has been the American Cancer Society Professor of the Department of Genome Sciences and of Medical Genetics in the Department of Medicine at the University of Washington since 1995. King received her undergraduate degree in mathematics from Carleton College in 1967. She was accepted into the graduate program at the University of California, Berkeley. In her doctoral work at Berkeley, king demonstrated through comparative protein analysis that chimpanzees and humans were 99% genetically identical. King completed her thesis in 1972, and received her doctorate in genetics in 1973. She then went to Santiago, Chile to teach at the Universidad de Chile. King accepted a faculty appointment at the University of California, Berkeley, as a professor of genetics and epidemiology in 1976. She remained at UC Berkeley until 1995, when she accepted an appointment as the American Cancer Society Professor at the University of Washington. She also served on the Life Sciences jury for the Infosys Prize in 2015. She has received many awards including the Lasker Award and the National Medal of Science. In 2002, Discover magazine recognized Dr. King as one of the 50 most important women in science.

Dr. Andrew Futreal is a Professor and Department Chair of the Department of Genomic Medicine in the Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center. He received his BS in Biology from the University of North Carolina, Charlotte in 1987 and went on to received his PhD in Pathology from the University of North Carolina, Chapel Hill in 1993. He conducted his postgraduate training at the National Institute of Environmental Health Sciences at the National Institutes of Health in Chapel Hill between 1993 and 1995. He also has served as the Co-director of the Cancer Genome Project since 2000. He has many awards and honors including the National Institutes of Health Award of Merit, the UT System STARS Awards from University of Texas, Honorary Faculty Member at the Wellcome Trust Sanger Institute, and the Ernst W. Bertner Memorial Award from the Genomic Architecture of Human Cancers. He is a member of the American Association for the Advancement of Science and the American Society of Clinical Oncology, amongst many others.